TARC
NSE
₹ 0.00
0.00 (0.00)%
Small-cap
With a market cap of ₹18.90L Cr.
EX-Date | Purpose |
---|---|
30 06 2021 | Audited Results |
14 08 2021 | Quarterly Results |
12 10 2021 | A.G.M. Inter alia, to consider and approve : 1. To convene 5th Annual General Meeting of the Company and fix the day, date and time of the meeting. 2. To consider and approve notice of the Annual General Meeting and other related documents. 3. To fix the date of book closure for the Annual General Meeting. |
13 11 2021 | Quarterly Results (Revised) |
14 02 2022 | Quarterly Results |
10 03 2022 | Inter alia, to consider and approve : (i) the proposal for raising funds by way of issuance of non-convertible debentures on private placement basis, in one or more tranches, the terms of the issue and other related issues; and (ii) consider conducting an Extra- Ordinary General Meeting to seek approval of the shareholders in respect of the aforesaid proposal and related matters. |
30 05 2022 | Audited Results |
10 08 2022 | Quarterly Results |
12 11 2022 | Quarterly Results |
13 02 2023 | Quarterly Results |
30 05 2023 | Audited Results |
11 08 2023 | Quarterly Results |
19 09 2023 | Inter alia, to consider the proposal for raising funds by way of issuance of non-convertible debentures on private placement basis, in one or more tranches, the terms of the issue and other related matters. |
09 11 2023 | Quarterly Results |
12 02 2024 | Quarterly Results |
27 09 2024 | Inter alia, to consider and approve the proposal for early redemption (partial) of NCDs and payment of interest thereon. |
06 11 2024 | Quarterly Results |
20 11 2024 | Inter alia, for considering the proposal for: (i) change in terms and conditions of the non-convertible debentures (NCDs) with respect to pre-mature full redemption of existing NCD s and payment thereof, subject to necessary approvals; and (ii) raising funds by way of issuance of non-convertible debentures (NCDs) on private placement basis, in one or more tranches, the terms of the issue and other related matter. |
06 02 2025 | Quarterly Results |
18 03 2025 | Inter alia, to consider and approve:- (i) modification in terms including amount of NCDs, issuance of which were approved by the Board at its meeting held on Nov 20, 2024 and (ii) change in terms and conditions of NCDs for pre-mature full redemption of existing NCDs and payment thereof |
No News data available